Tempsens Q1 FY27 consolidated revenue Rs 1,187.07 mn, PAT Rs 162.66 mn
Tempsens Instruments (India) Ltd reported Q1 FY27 consolidated revenue from operations of Rs 1,187.07 mn and profit after tax of Rs 162.66 mn, up from Rs 890.16 mn and Rs 140.76 mn in Q1 FY26.
Key takeaways
- Revenue from operations rose to Rs 1,187.07 million from Rs 890.16 million in Q1 FY26.
- Total income increased to Rs 1,208.70 million from Rs 909.78 million a year earlier.
- Total expenses were Rs 1,001.60 million versus Rs 730.37 million in Q1 FY26.
- Profit after tax was Rs 162.66 million, up from Rs 140.76 million in Q1 FY26.
Q1 FY27 · consolidated
| Metric | Jun 2026 | Jun 2025 | Change |
|---|---|---|---|
| Revenue | Rs 1,187.07 million | Rs 890.16 million | +33.4% |
| PAT | Rs 162.66 million | Rs 140.76 million | +15.6% |
As reported in the filing. Figures are transcribed, not computed.
• Revenue from operations (Q1 FY27, consolidated): Rs 1,187.07 million, vs Rs 890.16 million in Q1 FY26 (statement of financial results – consolidated quarterly income statement).
• Total income (Q1 FY27, consolidated): Rs 1,208.70 million, vs Rs 909.78 million in Q1 FY26 (statement of financial results – consolidated quarterly income statement).
• Profit before tax (Q1 FY27, consolidated): Rs 213.86 million, vs Rs 184.07 million in Q1 FY26 (statement of financial results – consolidated quarterly income statement).
• Profit after tax (Q1 FY27, consolidated): Rs 162.66 million, vs Rs 140.76 million in Q1 FY26 (statement of financial results – consolidated quarterly income statement).
• Total expenses (Q1 FY27, consolidated): Rs 1,001.60 million, vs Rs 730.37 million in Q1 FY26 (statement of financial results – consolidated quarterly income statement).
• Cost of materials consumed (Q1 FY27, consolidated): Rs 669.03 million, vs Rs 475.20 million in Q1 FY26 (statement of financial results – consolidated quarterly income statement).
• Employee benefits expense (Q1 FY27, consolidated): Rs 204.45 million, vs Rs 141.04 million in Q1 FY26 (statement of financial results – consolidated quarterly income statement).
• Finance costs (Q1 FY27, consolidated): Rs 13.59 million, vs Rs 12.31 million in Q1 FY26 (statement of financial results – consolidated quarterly income statement).
• Depreciation and amortisation expense (Q1 FY27, consolidated): Rs 38.50 million, vs Rs 33.48 million in Q1 FY26 (statement of financial results – consolidated quarterly income statement).
• Other expenses (Q1 FY27, consolidated): Rs 120.32 million, vs Rs 91.83 million in Q1 FY26 (statement of financial results – consolidated quarterly income statement).
For the quarter ended 30 June 2026 (Q1 FY27), Tempsens Instruments (India) Ltd’s consolidated revenue from operations, as reported in the consolidated quarterly income statement, rose to Rs 1,187.07 million from Rs 890.16 million in the corresponding quarter a year earlier. Total income increased to Rs 1,208.70 million from Rs 909.78 million over the same period.
On the cost side, total expenses moved up to Rs 1,001.60 million in Q1 FY27 from Rs 730.37 million in Q1 FY26. Within this, cost of materials consumed increased to Rs 669.03 million from Rs 475.20 million, while employee benefits expense rose to Rs 204.45 million from Rs 141.04 million. Depreciation and amortisation expense was Rs 38.50 million compared with Rs 33.48 million a year earlier, and finance costs were Rs 13.59 million versus Rs 12.31 million. Other expenses increased to Rs 120.32 million from Rs 91.83 million.
After accounting for expenses, profit before tax, as shown in the consolidated quarterly income statement, stood at Rs 213.86 million for Q1 FY27, compared with Rs 184.07 million in Q1 FY26. Profit after tax for the quarter was Rs 162.66 million, up from Rs 140.76 million in the same quarter of the previous year.
Track Tempsens Instruments (India) Ltd
Cruxal reads every Tempsens Instruments (India) Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.
